pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation - Wikidata - awgldk - TriplyDB

pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation

pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation

http://www.wikidata.org/entity/Q34753344

about

Tracheal development and the von Hippel-Lindau tumor suppressor homolog in Drosophila Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein von Hippel-Lindau disease: a clinical and scientific review Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study Therapeutic challenges in renal cell carcinoma Computational and experimental characterization of dVHL establish a Drosophila model of VHL syndrome Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma The von Hippel-Lindau tumour suppressor interacts with microtubules through kinesin-2 Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein Identification of 3 novel VHL germ-line mutations in Danish VHL patients RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program.Differences in regulation of tight junctions and cell morphology between VHL mutations from disease subtypes.Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification.Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near future Screening children at risk of developing inherited endocrine neoplasia syndromes.Sporadic endocrine tumours and their relationship to the hereditary endocrine neoplasia syndromes.VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling.The von Hippel-Lindau protein interacts with heteronuclear ribonucleoprotein a2 and regulates its expression.Proteomic dissection of the von Hippel-Lindau (VHL) interactome.Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity.VHL, the story of a tumour suppressor gene.Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells.Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3.The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing.The multifaceted von Hippel-Lindau tumour suppressor protein.Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization.Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability.Ubiquitin pathway in VHL cancer syndrome.HIF hydroxylation and the mammalian oxygen-sensing pathway The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity.Oxygen sensing in cancer.Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL.Association of the von Hippel-Lindau protein with AUF1 and posttranscriptional regulation of VEGFA mRNA.Pathological and molecular biological aspects of the renal epithelial neoplasms, up-to-date.Relevance of nuclear and cytoplasmic von hippel lindau protein expression for renal carcinoma progression.

P2860

Q22254253-3403F244-06F9-4415-B3D3-70DDE9D618D6 Q24298032-5661535F-3C59-401D-8998-3E96B22FBF99 Q24303868-D7E2DF4A-1806-4CAA-A72B-50D2F09F1BCD Q24563543-3DA3405A-94C2-42DC-A253-EC0E3A1CB5CA Q24622030-DDDC1427-CE52-4B01-BCB3-A74499362EF4 Q24634352-F18AEDFC-9244-472B-9CF2-4AB6427C2E10 Q24813050-42FBD1FD-1996-47CB-A73F-CB3E3CFF5895 Q26796702-B556B415-8976-4D76-8B1F-22BA56E66007 Q27336383-E6EE9C35-4EE3-4CE8-B00E-9ED98B3D586B Q27824855-A77FFDB6-5E48-4F3D-A1B5-163E91048EDD Q27851432-F6FBCC0A-DBB1-41B7-A38A-6BCF6D8B0BC5 Q28594394-91F4D10D-59A6-4846-A6FC-30B0215831E3 Q28647626-A9F0C5D0-399C-497F-A989-174C315811D4 Q31072855-DE978C82-10CC-4D09-8B4A-5D3383AD8A80 Q33292271-CA428641-B141-4791-9FD9-61BED5DDEDA2 Q33481999-507EE4D7-6D0D-42BD-B4E7-A30034CD271A Q33543092-B4AE64E6-9E59-418B-86C1-789571592816 Q33599713-FE666BCC-AF14-4506-9796-CCE3FAED7623 Q33836070-B845CE9D-8E7A-46CF-A1E6-4DA267324CCC Q33940347-4B6CD08A-B794-4374-A390-71B00B76560A Q33967117-866C86CF-432B-4037-920B-AECC68EC9CA0 Q34087732-1D0A1231-17CE-4D36-9A20-B4BBBAFBABD5 Q34218966-DCF8C5AA-3559-48EF-B3AF-CF82706B728C Q34323668-D3BDBF8B-C1D7-4528-A822-032713A780F8 Q34455226-8DFB44E4-3326-483D-83E0-CFA4EE31C210 Q34530199-659AFD73-D6B7-4DCA-8FE1-C4ED21620E26 Q34536583-D9E766FF-8F40-4E6F-B1DD-44006F66B7F5 Q34569182-D7D8D6AF-6C98-4CD5-A36C-8468B41AB6DA Q34569380-48F4B22F-FA19-41F3-8642-6ADFA8B8A8B3 Q34660062-677DE441-594A-4A98-B445-11924A5CD619 Q34718191-59CFB18F-9667-4E4D-8733-DA43BF44E9A8 Q35005618-E71F9CAD-ADF4-4162-9D03-92F62A136F81 Q35082720-4D2694BD-1169-419A-B811-C9E325A5BD41 Q35086143-4440B2AF-242F-40ED-AEE7-F250259E95AB Q35201819-279A2476-F7CC-4325-A10F-EADFAA97FC1F Q35565483-69D89815-1084-4080-B387-321484A5A6F9 Q35589987-13E03550-FDA3-4271-87C5-C7DCF9FDC29D Q35683322-BFA5A762-BCEA-460F-B072-ED61997F8080 Q35773595-B632CCDD-FD37-4401-BDC6-35EF7C3A75DD Q35792041-1B82E52D-2BD9-4700-9BB6-B4A6EA3B93AF

P2860

pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation

http://www.wikidata.org/entity/Q34753344

description

1998 nî lūn-bûn

@nan

1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

pVHL19 is a biologically activ ...... nternal translation initiation

@ast

pVHL19 is a biologically activ ...... nternal translation initiation

@en

pVHL19 is a biologically activ ...... nternal translation initiation

@nl

type

label

pVHL19 is a biologically activ ...... nternal translation initiation

@ast

pVHL19 is a biologically activ ...... nternal translation initiation

@en

pVHL19 is a biologically activ ...... nternal translation initiation

@nl

prefLabel

pVHL19 is a biologically activ ...... nternal translation initiation

@ast

pVHL19 is a biologically activ ...... nternal translation initiation

@en

pVHL19 is a biologically activ ...... nternal translation initiation

@nl

P1433

Q34753344-6734EC16-31DD-4391-9A8F-B40B285B2759

P1476

Q34753344-2BDDB721-C5D6-4A4A-9724-BA4BA1C00E3D

P2093

Q34753344-4ED3FFED-0CDA-4518-8635-07DDD76CC1A3

Q34753344-54368C75-5B8F-4C7B-82EC-CA14C05E5882

P2860

Q34753344-05E4B5E9-0C9B-462C-A8E5-E888BAF34AE5

Q34753344-0BE28D34-85E0-4C21-A6A5-00E39E54BB74

Q34753344-0E7FDFBA-9B58-4EE7-8B0E-20BFC9D142F2

Q34753344-1D9ACBFF-7477-4708-B81A-75F64D0BF987

Q34753344-2000F3AE-CEF3-4568-BF1F-1C575E1C2189

Q34753344-2690DB8E-A680-4416-A043-E437CC2DEFC8

Q34753344-2F4EDBF4-BB03-4E2F-A7C8-2F9C8864519C

Q34753344-2FE6472E-93C1-4077-9B4A-B3E5A7C06D29

Q34753344-3BF982BD-1C4F-4907-857D-29F06C69762C

Q34753344-3E384D2B-6E98-496A-A225-12144D613326

P304

Q34753344-550D7834-685D-46F3-AC66-456EF7094742

P31

Q34753344-07FB1E03-BC61-4D11-BB40-EEF9B54F364B

P356

Q34753344-EBA395EC-AC64-400F-BC32-D3F8E1697B0A

P407

Q34753344-0E5ADE41-C055-4F2F-BC6C-84E4099A99F9

P433

Q34753344-C480BCEB-DDA7-42FC-A7A7-F41A758965E2

P478

Q34753344-4E18CA01-D3A5-4CE3-92BB-ED40118D7FFC

P50

Q34753344-E0D67187-E66C-4737-8EA6-027E558B74DF

P577

Q34753344-F5E2AD9B-3BAC-4FAC-B318-5303CAB21906

P5875

Q34753344-1C645F6B-4569-4237-84FA-A48731F225CA

P698

Q34753344-4053B13F-C2EE-4273-8904-966B3A3C1473

P932

Q34753344-FC35F3AB-F974-4F74-8A84-B97D0E44FF21

P356

PNAS.95.20.11661

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

pVHL19 is a biologically activ ...... nternal translation initiation

@en

P2093

M Ohh

http://www.w3.org/2001/XMLSchema#string

O Iliopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity

Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations

Inhibition of transcription elongation by the VHL tumor suppressor protein

Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C

Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2

The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins

Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes

The scanning model for translation: an update

Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1-to-S-phase transition and identifies a conserved family of proteins.

P304

11661-11666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.95.20.11661

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

William G. Kaelin

P577

1998-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13533708

http://www.w3.org/2001/XMLSchema#string

P698

9751722

http://www.w3.org/2001/XMLSchema#string

P932

21697

http://www.w3.org/2001/XMLSchema#string